Cytovance Biologics Capacity Update January 2025: Large Molecule Development

Located in the heart of the United States, Cytovance brings decades of expertise in biologics development and cGMP manufacturing. With a proven track record of innovation, we provide end-to-end solutions for both large pharmaceutical companies and biotech firms.

Join Rose Rhomberg, Senior Business Development Director, as she showcases Cytovance’s microbial and mammalian capabilities, along with our available manufacturing capacity.